SODIUM CHLORIDE INJECTION, USP, 0.9%, 20 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only...

FDA Drug Recall #D-0299-2019 — Class I — November 15, 2018

Recall Summary

Recall Number D-0299-2019
Classification Class I — Serious risk
Date Initiated November 15, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Kabi USA, LLC
Location Grand Island, NY
Product Type Drugs
Quantity 1,312,350 20 mL vials

Product Description

SODIUM CHLORIDE INJECTION, USP, 0.9%, 20 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173. NDC 63323-186-20, Product code 918620

Reason for Recall

Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex. The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex. The above listed product codes and batches being recalled have stoppers containing natural rubber latex.

Distribution Pattern

Distributed Nationwide in the USA and Puerto RIco

Lot / Code Information

Lot# EXP date: 6013062 11/2018 6014162 05/2019 6014163 05/2019 6014164 05/2019 6014377 06/2019 6014378 06/2019 6014379 06/2019 6016005 02/2020 6016071 02/2020 6016072 02/2020 6016073 02/2020 6017383 07/2020 6017384 07/2020 6017422 07/2020 6017423 07/2020 6017424 07/2020

Other Recalls from Fresenius Kabi USA, LLC

Recall # Classification Product Date
D-0426-2026 Class II 0.9% Sodium Chloride Injection, USP, 0.9% (900 ... Mar 11, 2026
D-0427-2026 Class II 0.9% Sodium Chloride Injection, USP, (2,250 mg ... Mar 11, 2026
D-0434-2026 Class II 0.9% Sodium Chloride Injection, USP 900 mg per ... Mar 11, 2026
D-0424-2026 Class II 0.45% Sodium Chloride Injection, USP, 1.125 gra... Mar 11, 2026
D-0432-2026 Class II 0.9% Sodium Chloride Injection, USP 900 mg per ... Mar 11, 2026

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.